Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
It may be possible to stop the progression of Parkinson's disease with a drug normally used in type 2 diabetes, a clinical trial suggests.
Current drugs help manage the symptoms, but do not prevent brain cells dying.
The trial on 62 patients, published in the Lancet, hints the medicine halted the progression of the disease.
The University College London (UCL) team is "excited", but it urges caution as any long-term benefit is uncertain and the drug needs more testing.
"There's absolutely no doubt the most important unmet need in Parkinson's is a drug to slow down disease progression, it's unarguable," Prof Tom Foltynie, one of the researchers, told the BBC.
http://www.bbc.co.uk/news/health-40814250
Exenatide = Byetta. We used to get quite a few people here on Byetta and Victoza (liraglutide), but I haven't seen either mentioned for ages now.
Current drugs help manage the symptoms, but do not prevent brain cells dying.
The trial on 62 patients, published in the Lancet, hints the medicine halted the progression of the disease.
The University College London (UCL) team is "excited", but it urges caution as any long-term benefit is uncertain and the drug needs more testing.
"There's absolutely no doubt the most important unmet need in Parkinson's is a drug to slow down disease progression, it's unarguable," Prof Tom Foltynie, one of the researchers, told the BBC.
http://www.bbc.co.uk/news/health-40814250
Exenatide = Byetta. We used to get quite a few people here on Byetta and Victoza (liraglutide), but I haven't seen either mentioned for ages now.